Literature DB >> 14661

Studies of the effect of thyroid dysfunction on the elimination of beta-adrenoreceptor blocking drugs.

J M Bell, C J Russell, J K Nelson, J G Kelly, D G McDevitt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 14661      PMCID： PMC1428989          DOI： 10.1111/j.1365-2125.1977.tb00672.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  12 in total

1.  Commentary: a physiological approach to hepatic drug clearance.

Authors:  G R Wilkinson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  The kinetics of propylthiouracil in hyperthyroidism.

Authors:  J Kampmann; L Skovsted
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975-09

3.  5-Hydroxytryptamine (5-HT) in the whole-blood of patients with depressive illness.

Authors:  A Coppen; P Turner; A R Rowsell; C Padgham
Journal:  Postgrad Med J       Date:  1976-03       Impact factor: 2.401

4.  Pharmacokinetic studies of practolol, a beta adrenergic antagonist, in man.

Authors:  G Bodem; C A Chidsey
Journal:  Clin Pharmacol Ther       Date:  1973 Jan-Feb       Impact factor: 6.875

Review 5.  Beta-adrenergic receptor blocking drugs in hyperthyroidism.

Authors:  P Turner
Journal:  Drugs       Date:  1974       Impact factor: 9.546

6.  Inhibition of drug metabolism in man.

Authors:  E S Vesell; G T Passananti
Journal:  Drug Metab Dispos       Date:  1973 Jan-Feb       Impact factor: 3.922

7.  Blood levels of practolol after oral and parenteral administration and their relationship to exercise heart rate.

Authors:  S G Carruthers; J G Kelly; D G McDevitt; R G Shanks
Journal:  Clin Pharmacol Ther       Date:  1974-05       Impact factor: 6.875

8.  Plasma propranolol levels in adults with observations in four children.

Authors:  D G Shand; E M Nuckolls; J A Oates
Journal:  Clin Pharmacol Ther       Date:  1970 Jan-Feb       Impact factor: 6.875

9.  Serum digoxin in patients with thyroid disease.

Authors:  M S Croxson; H K Ibbertson
Journal:  Br Med J       Date:  1975-09-06

Review 10.  Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs.

Authors:  D G Shand
Journal:  Drugs       Date:  1974       Impact factor: 9.546
View more
  13 in total

Review 1.  Influence of thyroid dysfunction on drug pharmacokinetics.

Authors:  G M Shenfield
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.

Authors:  J Feely
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

3.  No Dataset Left Behind: Mechanistic Insights into Thyroid Receptor Signaling Through Transcriptomic Consensome Meta-Analysis.

Authors:  Scott A Ochsner; Neil J McKenna
Journal:  Thyroid       Date:  2020-01-29       Impact factor: 6.568

4.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

Review 5.  Clinical pharmacokinetics and endocrine disorders. Therapeutic implications.

Authors:  P O'Connor; J Feely
Journal:  Clin Pharmacokinet       Date:  1987-12       Impact factor: 6.447

6.  Absence of changes in drug disposition and catecholamine sensitivity in the hyperthyroid dog.

Authors:  T Ishizaki; K Tawara
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

Review 7.  Use of beta-adrenoceptor blocking drugs in hyperthyroidism.

Authors:  J Feely; N Peden
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

8.  Evolution of atenolol kinetics when hypothyroidism is corrected.

Authors:  H Levesque; M O Richard; J Fresel; A Gancel; N Moore; H Courtois
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

9.  Left ventricular function in hypothyroidism. Responses to exercise and beta adrenoceptor blockade.

Authors:  J C Forfar; A L Muir; A D Toft
Journal:  Br Heart J       Date:  1982-09

10.  Comparison of propranolol and metoprolol in the management of hyperthyroidism.

Authors:  L E Murchison; J How; P D Bewsher
Journal:  Br J Clin Pharmacol       Date:  1979-12       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.